US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Northwest Biotherapeutics, Inc.

0.2420

+0.00903.88%

Volume:1.04M

Turnover:249.21K

Market Cap:386.51M

PE:-3.71

High:0.2467

Open:0.2301

Low:0.2300

Close:0.2330

52wk High:0.4788

52wk Low:0.1685

Shares:1.60B

Float Shares:1.56B

Volume Ratio:0.83

T/O Rate:0.07%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.0652

EPS(LYR):-0.0575

ROE:276.45%

ROA:-135.39%

PB:-3.56

PE(LYR):-4.21

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Northwest Biotherapeutics, Inc.

Exchange:

OTCQB

Establishment Date:

1996

Employees:

25

Office Location:

4800 Montgomery Lane,Suite 800,Bethesda,Maryland,United States

Website:

http://www.nwbio.com

Zip Code:

20814

Phone:

Fax:

- -

Introduction:

Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Its lead product, DCVax-L, which has completed Phase III clinical trials to treat Glioblastoma multiforme brain cancer. The company also develops DCVax-Direct, which is in Phase I/II clinical trials to treat inoperable solid tumors. The company was founded in 1996 and is headquartered in Bethesda, Maryland.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/NWBO/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NWBO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NWBO\",,,,,undefined,":{"symbol":"NWBO","market":"US","secType":"STK","nameCN":"Northwest Biotherapeutics, Inc.","latestPrice":0.24204,"timestamp":1771441440000,"preClose":0.233,"halted":0,"volume":1040676,"delay":15,"changeRate":0.03879828326180254,"floatShares":1559899871,"shares":1596881409,"eps":-0.065174,"marketStatus":"Trading","change":0.00904,"latestTime":"02-18 14:04:00 EST Delay","open":0.2301,"high":0.2467,"low":0.23,"amount":249211.36856616,"amplitude":0.071674,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.065174,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1771448400000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"OTCQB","adjPreClose":0.233,"volumeRatio":0.830974},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NWBO\",,,,,undefined,":{"symbol":"NWBO","floatShares":1559899871,"roa":"-135.39%","roe":"276.45%","lyrEps":-0.057517,"volumeRatio":0.830974,"shares":1596881409,"dividePrice":0,"high":0.2467,"amplitude":0.071674,"preClose":0.233,"low":0.23,"week52Low":0.16845,"pbRate":"-3.56","psRate":"412.50","week52High":0.4788,"institutionHeld":0.001,"latestPrice":0.24204,"eps":-0.065174,"divideRate":0,"volume":1040676,"delay":15,"ttmEps":-0.065174,"open":0.2301,"prevYearClose":0.22875,"prevWeekClose":0.24,"prevMonthClose":0.2909,"prevQuarterClose":0.2288,"fiveDayClose":0.2505,"twentyDayClose":0.2909,"sixtyDayClose":0.2378},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NWBO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-11-12","symbol":"NWBO","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-08-09","symbol":"NWBO","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723176000000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-05-10","symbol":"NWBO","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715313600000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-03-05","symbol":"NWBO","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1709614800000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2023-11-09","symbol":"NWBO","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1699506000000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NWBO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NWBO\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":1342115,"yearFounded":1996,"employeeNum":25,"address":"4800 Montgomery Lane,Suite 800,Bethesda,Maryland,United States","zipCode":"20814","officePhone":"240 497 9024"},"stockCompanyDetail":{"websiteUrl":"http://www.nwbio.com","stockEarnings":[{"period":"1week","weight":-0.0167},{"period":"1month","weight":-0.1296},{"period":"3month","weight":-0.0208},{"period":"6month","weight":-0.2047},{"period":"1year","weight":0.2368},{"period":"ytd","weight":0.1436}],"description":"Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Its lead product, DCVax-L, which has completed Phase III clinical trials to treat Glioblastoma multiforme brain cancer. The company also develops DCVax-Direct, which is in Phase I/II clinical trials to treat inoperable solid tumors. The company was founded in 1996 and is headquartered in Bethesda, Maryland.","exchange":"OTCQB","name":"Northwest Biotherapeutics, Inc.","nameEN":"Northwest Biotherapeutics, Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"NWBO\",market:\"US\",,,undefined,":null}}